Description:
GLP-1 agonists were approved by the FDA for weight loss in late 2014. It's a newer class of drugs better known
for its ability to improve blood sugar control. These medications were actually designed to treat type II diabetes,
but some have also been FDA approved to treat weight loss. The GLP-1 agonists we work with are called Semaglutide
& Tirzepatide.
Function&Application:
1.Weight loss
2.Anti-diabetes
3.Alzheimer's disease